Automated CD34+ cell isolation of peripheral blood stem cell apheresis product.
暂无分享,去创建一个
Volker Huppert | Mike Essl | Juliane Stuth | Christiane Hümmer | E. Seifried | H. Bönig | E. Wiercinska | Halvard Bönig | Gabriele Spohn | Erhard Seifried | Darja Karpova | Carolin Poppe | Milica Bunos | Eva Wingenfeld | Kristina Reck | Eliza Wiercinska | Nadine Sorg | G. Spohn | D. Karpova | V. Huppert | M. Essl | C. Poppe | Kristina Reck | M. Bunos | N. Sorg | E. Wingenfeld | C. Hümmer | Juliane Stuth | Gabriele Spohn | Milica Bunos | Christiane Hümmer | Eva Wingenfeld | Nadine Sorg
[1] F. Appelbaum,et al. Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] L. Kanz,et al. Clinical Applications of CD34+ Peripheral Blood Progenitor Cells (PBPC) , 2000, Stem cells.
[3] E. Seifried,et al. Pediatric apheresis with a novel apheresis device with electronic interface control , 2013, Transfusion.
[4] E. Seifried,et al. Red blood cell depletion from bone marrow and peripheral blood buffy coat: a comparison of two new and three established technologies , 2015, Transfusion.
[5] David D. Smith,et al. Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] H. Atkins,et al. Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] F Beaujean,et al. Methods of CD34+ cell separation: comparative analysis. , 1997, Transfusion Science.
[8] E. Seifried,et al. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G‐CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5‐year follow‐up study , 2013, Vox sanguinis.
[9] A. Komatsuda,et al. Clinical Applications of CD34+ Cell‐selected Peripheral Blood Stem Cells , 2003, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[10] J. Antin,et al. Hematopoietic stem cell transplantation donor sources in the 21 st century : choosing the ideal donor when a perfect match does not exist , 2014 .
[11] E. Seifried,et al. Allogeneic donor peripheral blood “stem cell” apheresis: prospective comparison of two apheresis systems , 2012, Transfusion.
[12] E. Shpall,et al. Isolation of CD34-positive hematopoietic progenitor cells. , 1994, ImmunoMethods.
[13] A. Bosio,et al. Isolation and enrichment of stem cells. , 2009, Advances in biochemical engineering/biotechnology.
[14] Stefan Miltenyi,et al. Integrated Clinical Scale Manufacturing System for Cellular Products Derived by Magnetic Cell Separation, Centrifugation and Cell Culture , 2013 .
[15] M. Schmidt,et al. Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates , 2014, Bone Marrow Transplantation.
[16] J. Antin,et al. Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist. , 2014, Blood.
[17] J. Fish,et al. Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors. , 2010, Pediatric clinics of North America.
[18] E. Seifried,et al. Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface‐controlled apheresis system: results from the first feasibility trial , 2011, Vox sanguinis.
[19] E. Seifried,et al. Enumeration of viable CD34(+) cells by flow cytometry in blood, bone marrow and cord blood: results of a study of the novel BD™ stem cell enumeration kit. , 2011, Cytotherapy.
[20] J. Briones,et al. Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood. , 1997, Blood.
[21] P. Hari,et al. Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.